{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:08:58Z","timestamp":1790780938646,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["ZR2021MH090"],"award-info":[{"award-number":["ZR2021MH090"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Qingdao Outstanding Health Professional Development Fund"},{"name":"Young Elite Sponsorship Program of Shandong Provincial Medical Association"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s11010-024-05073-2","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T14:03:09Z","timestamp":1723039389000},"page":"1669-1684","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Targeting BRD4 to attenuate RANKL-induced osteoclast activation and bone erosion in rheumatoid arthritis"],"prefix":"10.1007","volume":"480","author":[{"given":"Changyao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongtao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,7]]},"reference":[{"issue":"5","key":"5073_CR1","first-page":"872","volume":"37","author":"LX Zheng","year":"2019","unstructured":"Zheng LX, Li KX, Hong FF, Yang SL (2019) Pain and bone damage in rheumatoid arthritis: role of leukotriene B4. Clin Exp Rheumatol 37(5):872\u2013878 (PMID: 30943138)","journal-title":"Clin Exp Rheumatol"},{"issue":"10086","key":"5073_CR2","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1016\/S0140-6736(17)31472-1","volume":"389","author":"IB McInnes","year":"2017","unstructured":"McInnes IB, Schett G (2017) Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet 389(10086):2328\u20132337. https:\/\/doi.org\/10.1016\/S0140-6736(17)31472-1. (PMID: 28612747)","journal-title":"Lancet"},{"issue":"4","key":"5073_CR3","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3390\/cells9040880","volume":"9","author":"YJ Lin","year":"2020","unstructured":"Lin YJ, Anzaghe M, Schulke S (2020) Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis. Cells 9(4):880. https:\/\/doi.org\/10.3390\/cells9040880. (PMID: 32260219)","journal-title":"Cells"},{"key":"5073_CR4","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.intimp.2019.03.008","volume":"70","author":"XX Hu","year":"2019","unstructured":"Hu XX, Wu YJ, Zhang J, Wei W (2019) T-cells interact with B cells, dendritic cells, and fibroblast-like synoviocytes as hub-like key cells in rheumatoid arthritis. Int Immunopharmacol 70:428\u2013434. https:\/\/doi.org\/10.1016\/j.intimp.2019.03.008. (PMID: 30856393)","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"5073_CR5","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41584-020-0413-5","volume":"16","author":"G Nygaard","year":"2020","unstructured":"Nygaard G, Firestein GS (2020) Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes. Nat Rev Rheumatol 16(6):316\u2013333. https:\/\/doi.org\/10.1038\/s41584-020-0413-5. (PMID: 32393826)","journal-title":"Nat Rev Rheumatol"},{"key":"5073_CR6","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.3389\/fimmu.2019.01395","volume":"10","author":"H Yoshitomi","year":"2019","unstructured":"Yoshitomi H (2019) Regulation of immune responses and chronic inflammation by fibroblast-like synoviocytes. Front Immunol 10:1395. https:\/\/doi.org\/10.3389\/fimmu.2019.01395. (PMID: 31275325)","journal-title":"Front Immunol"},{"key":"5073_CR7","doi-asserted-by":"publisher","first-page":"3830212","DOI":"10.1155\/2020\/3830212","volume":"2020","author":"Q Fang","year":"2020","unstructured":"Fang Q, Zhou C, Nandakumar KS (2020) Molecular and cellular pathways contributing to joint damage in rheumatoid arthritis. Mediat Inflamm 2020:3830212. https:\/\/doi.org\/10.1155\/2020\/3830212. (PMID: 32256192)","journal-title":"Mediat Inflamm"},{"key":"5073_CR8","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.intimp.2018.10.016","volume":"65","author":"AK Rana","year":"2018","unstructured":"Rana AK, Li Y, Dang Q, Yang F (2018) Monocytes in rheumatoid arthritis: circulating precursors of macrophages and osteoclasts and their heterogeneity and plasticity role in RA pathogenesis. Int Immunopharmacol 65:348\u2013359. https:\/\/doi.org\/10.1016\/j.intimp.2018.10.016. (PMID: 30366278)","journal-title":"Int Immunopharmacol"},{"key":"5073_CR9","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.3389\/fimmu.2018.02847","volume":"9","author":"F Liu","year":"2018","unstructured":"Liu F, Feng XX, Zhu SL et al (2018) Sonic hedgehog signaling pathway mediates proliferation and migration of fibroblast-like synoviocytes in rheumatoid arthritis via MAPK\/ERK signaling pathway. Front Immunol 9:2847. https:\/\/doi.org\/10.3389\/fimmu.2018.02847. (PMID: 30568656)","journal-title":"Front Immunol"},{"issue":"5","key":"5073_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nrrheum.2013.17","volume":"9","author":"AM Grabiec","year":"2013","unstructured":"Grabiec AM, Reedquist KA (2013) The ascent of acetylation in the epigenetics of rheumatoid arthritis. NAT Rev Rheumatol 9(5):311\u2013318. https:\/\/doi.org\/10.1038\/nrrheum.2013.17. (PMID: 23439035)","journal-title":"NAT Rev Rheumatol"},{"issue":"5","key":"5073_CR11","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.4049\/jimmunol.0901467","volume":"184","author":"AM Grabiec","year":"2010","unstructured":"Grabiec AM, Krausz S, de Jager W et al (2010) Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue. J Immunol 184(5):2718\u20132728. https:\/\/doi.org\/10.4049\/jimmunol.0901467. (PMID: 20100935)","journal-title":"J Immunol"},{"issue":"3","key":"5073_CR12","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/ard.2011.154211","volume":"71","author":"AM Grabiec","year":"2012","unstructured":"Grabiec AM, Korchynskyi O, Tak PP, Reedquist KA (2012) Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay. Ann Rheum Dis 71(3):424\u2013431. https:\/\/doi.org\/10.1136\/ard.2011.154211. (PMID: 21953341)","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"5073_CR13","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/art.33382","volume":"64","author":"J Gillespie","year":"2012","unstructured":"Gillespie J, Savic S, Wong C et al (2012) Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3-selective inhibitor reduces interleukin-6 production by peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Rheum 64(2):418\u2013422. https:\/\/doi.org\/10.1002\/art.33382. (PMID: 21952924)","journal-title":"Arthritis Rheum"},{"issue":"2","key":"5073_CR14","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","volume":"153","author":"J Loven","year":"2013","unstructured":"Loven J, Hoke HA, Lin CY et al (2013) Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153(2):320\u2013334. https:\/\/doi.org\/10.1016\/j.cell.2013.03.036. (PMID: 23582323)","journal-title":"Cell"},{"issue":"11","key":"5073_CR15","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.tcb.2014.09.005","volume":"24","author":"Y Xu","year":"2014","unstructured":"Xu Y, Vakoc CR (2014) Brd4 is on the move during inflammation. Trends Cell Biol 24(11):615\u2013616. https:\/\/doi.org\/10.1016\/j.tcb.2014.09.005. (PMID: 25288306)","journal-title":"Trends Cell Biol"},{"key":"5073_CR16","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2018100293","author":"A Dey","year":"2019","unstructured":"Dey A, Yang W, Gegonne A et al (2019) BRD4 directs hematopoietic stem cell development and modulates macrophage inflammatory responses. Embo J. https:\/\/doi.org\/10.15252\/embj.2018100293. (PMID: 30842097)","journal-title":"Embo J"},{"issue":"12","key":"5073_CR17","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1016\/j.bbadis.2017.08.009","volume":"1863","author":"Y Jiang","year":"2017","unstructured":"Jiang Y, Zhu L, Zhang T et al (2017) BRD4 has dual effects on the HMGB1 and NF-kappaB signalling pathways and is a potential therapeutic target for osteoarthritis. BBA\u2014Mol Basis Dis. 1863(12):3001\u20133015. https:\/\/doi.org\/10.1016\/j.bbadis.2017.08.009. (PMID: 28844955)","journal-title":"BBA\u2014Mol Basis Dis."},{"issue":"1","key":"5073_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13148-021-01008-6","volume":"13","author":"Z Huang","year":"2021","unstructured":"Huang Z, Yang R, Zhang L et al (2021) BRD4 inhibition alleviates mechanical stress-induced TMJ OA-like pathological changes and attenuates TREM1-mediated inflammatory response. Clin Epigenetics 13(1):10. https:\/\/doi.org\/10.1186\/s13148-021-01008-6. (PMID: 33446277)","journal-title":"Clin Epigenetics"},{"issue":"6","key":"5073_CR19","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1158\/2159-8290.CD-16-0217","volume":"6","author":"N Tasdemir","year":"2016","unstructured":"Tasdemir N, Banito A, Roe JS et al (2016) BRD4 connects enhancer remodeling to senescence immune surveillance. Cancer Discov 6(6):612\u2013629. https:\/\/doi.org\/10.1158\/2159-8290.CD-16-0217. (PMID: 27099234)","journal-title":"Cancer Discov"},{"issue":"24","key":"5073_CR20","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1111\/bph.16195","volume":"180","author":"J Sun","year":"2023","unstructured":"Sun J, Wang XH, Song FH et al (2023) Inhibition of Brd4 alleviates osteoarthritis pain via suppression of neuroinflammation and activation of Nrf2-mediated antioxidant signalling. Brit J Pharmacol. 180(24):3194\u20133214. https:\/\/doi.org\/10.1111\/bph.16195. (PMID: 37485568)","journal-title":"Brit J Pharmacol."},{"issue":"7327","key":"5073_CR21","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/nature09504","volume":"468","author":"P Filippakopoulos","year":"2010","unstructured":"Filippakopoulos P, Qi J, Picaud S et al (2010) Selective inhibition of BET bromodomains. Nature 468(7327):1067\u20131073. https:\/\/doi.org\/10.1038\/nature09504. (PMID: 20871596)","journal-title":"Nature"},{"issue":"7","key":"5073_CR22","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.4049\/jimmunol.1202838.PMID:23420887.66","volume":"190","author":"AC Belkina","year":"2013","unstructured":"Belkina AC, Nikolajczyk BS, Denis GV (2013) BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses. J Immunol 190(7):3670\u20133678. https:\/\/doi.org\/10.4049\/jimmunol.1202838.PMID:23420887.66","journal-title":"J Immunol"},{"issue":"7","key":"5073_CR23","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1177\/0022034514534261","volume":"93","author":"S Meng","year":"2014","unstructured":"Meng S, Zhang L, Tang Y et al (2014) BET inhibitor JQ1 blocks inflammation and bone destruction. J Dent Res 93(7):657\u2013662. https:\/\/doi.org\/10.1177\/0022034514534261. (PMID: 24799421)","journal-title":"J Dent Res"},{"key":"5073_CR24","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1038\/ncomms4511","volume":"5","author":"F Lamoureux","year":"2014","unstructured":"Lamoureux F, Baud\u2019Huin M, Rodriguez CL et al (2014) Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle. Nat Commun 5:3511. https:\/\/doi.org\/10.1038\/ncomms4511. (PMID: 24646477)","journal-title":"Nat Commun"},{"key":"5073_CR25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.bone.2016.09.020","volume":"94","author":"M Baud\u2019Huin","year":"2017","unstructured":"Baud\u2019Huin M, Lamoureux F, Jacques C et al (2017) Inhibition of BET proteins and epigenetic signaling as a potential treatment for osteoporosis. Bone 94:10\u201321. https:\/\/doi.org\/10.1016\/j.bone.2016.09.020. (PMID: 27669656)","journal-title":"Bone"},{"issue":"5","key":"5073_CR26","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/nprot.2007.173","volume":"2","author":"DD Brand","year":"2007","unstructured":"Brand DD, Latham KA, Rosloniec EF (2007) Collagen-induced arthritis. Nat Protoc 2(5):1269\u20131275. https:\/\/doi.org\/10.1038\/nprot.2007.173. (PMID: 17546023)","journal-title":"Nat Protoc"},{"issue":"1","key":"5073_CR27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.joca.2009.08.009","volume":"18","author":"M Rutgers","year":"2010","unstructured":"Rutgers M, van Pelt MJ, Dhert WJ, Creemers LB, Saris DB (2010) Evaluation of histological scoring systems for tissue-engineered, repaired and osteoarthritic cartilage. Osteoarthr Cartilage 18(1):12\u201323. https:\/\/doi.org\/10.1016\/j.joca.2009.08.009. (PMID: 19747584)","journal-title":"Osteoarthr Cartilage"},{"issue":"10","key":"5073_CR28","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41584-022-00827-y","volume":"18","author":"A Finckh","year":"2022","unstructured":"Finckh A, Gilbert B, Hodkinson B et al (2022) Global epidemiology of rheumatoid arthritis. Nat Rev Rheumatol 18(10):591\u2013602. https:\/\/doi.org\/10.1038\/s41584-022-00827-y. (PMID: 36068354)","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"5073_CR29","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1136\/annrheumdis-2014-207137","volume":"75","author":"L Danks","year":"2016","unstructured":"Danks L, Komatsu N, Guerrini MM et al (2016) RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation. Ann Rheum Dis 75(6):1187\u20131195. https:\/\/doi.org\/10.1136\/annrheumdis-2014-207137. (PMID: 26025971)","journal-title":"Ann Rheum Dis"},{"key":"5073_CR30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI143060","author":"N Komatsu","year":"2021","unstructured":"Komatsu N, Win S, Yan M et al (2021) Plasma cells promote osteoclastogenesis and periarticular bone loss in autoimmune arthritis. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI143060. (PMID: 33720039)","journal-title":"J Clin Invest"},{"issue":"23","key":"5073_CR31","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. New Engl J Med 365(23):2205\u20132219. https:\/\/doi.org\/10.1056\/NEJMra1004965. (PMID: 22150039)","journal-title":"New Engl J Med"},{"issue":"7","key":"5073_CR32","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41419-021-03939-7","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu Y, Liu W, Yu Z et al (2021) A novel BRD4 inhibitor suppresses osteoclastogenesis and ovariectomized osteoporosis by blocking RANKL-mediated MAPK and NF-kappaB pathways. Cell Death Dis 12(7):654. https:\/\/doi.org\/10.1038\/s41419-021-03939-7. (PMID: 34175898)","journal-title":"Cell Death Dis"},{"issue":"2","key":"5073_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.imlet.2015.05.016","volume":"166","author":"QG Zhang","year":"2015","unstructured":"Zhang QG, Qian J, Zhu YC (2015) Targeting bromodomain-containing protein 4 (BRD4) benefits rheumatoid arthritis. Immunol Lett 166(2):103\u2013108. https:\/\/doi.org\/10.1016\/j.imlet.2015.05.016. (PMID: 26093279)","journal-title":"Immunol Lett"},{"issue":"2","key":"5073_CR34","doi-asserted-by":"publisher","first-page":"e1501257","DOI":"10.1126\/sciadv.1501257","volume":"2","author":"F Ghari","year":"2016","unstructured":"Ghari F, Quirke AM, Munro S et al (2016) Citrullination-acetylation interplay guides E2F\u20131 activity during the inflammatory response. Sci Adv 2(2):e1501257. https:\/\/doi.org\/10.1126\/sciadv.1501257. (PMID: 26989780)","journal-title":"Sci Adv"},{"issue":"11","key":"5073_CR35","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1073\/pnas.1615601114","volume":"114","author":"K Cheung","year":"2017","unstructured":"Cheung K, Lu G, Sharma R et al (2017) BET N-terminal bromodomain inhibition selectively blocks Th17 cell differentiation and ameliorates colitis in mice. Proc Natl Acad Sci USA 114(11):2952\u20132957. https:\/\/doi.org\/10.1073\/pnas.1615601114. (PMID: 28265070)","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"5073_CR36","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.molcel.2016.12.022","volume":"65","author":"KL Cheung","year":"2017","unstructured":"Cheung KL, Zhang F, Jaganathan A et al (2017) Distinct roles of Brd2 and Brd4 in potentiating the transcriptional program for Th17 cell differentiation. Mol Cell 65(6):1068\u20131080. https:\/\/doi.org\/10.1016\/j.molcel.2016.12.022. (PMID: 28262505)","journal-title":"Mol Cell"},{"key":"5073_CR37","doi-asserted-by":"publisher","first-page":"1021820","DOI":"10.3389\/fcell.2022.1021820","volume":"10","author":"X Shi","year":"2022","unstructured":"Shi X, Wang Y, Zhang L et al (2022) Targeting bromodomain and extra-terminal proteins to inhibit neuroblastoma tumorigenesis through regulating MYCN. Front Cell Dev Biol 10:1021820. https:\/\/doi.org\/10.3389\/fcell.2022.1021820. (PMID: 36187481)","journal-title":"Front Cell Dev Biol"},{"issue":"14","key":"5073_CR38","doi-asserted-by":"publisher","first-page":"8060","DOI":"10.1093\/nar\/gkab617","volume":"49","author":"T Sharma","year":"2021","unstructured":"Sharma T, Robinson D, Witwicka H, Dilworth FJ, Imbalzano AN (2021) The bromodomains of the mammalian SWI\/SNF (mSWI\/SNF) ATPases Brahma (BRM) and Brahma Related Gene 1 (BRG1) promote chromatin interaction and are critical for skeletal muscle differentiation. Nucleic Acids Res 49(14):8060\u20138077. https:\/\/doi.org\/10.1093\/nar\/gkab617. (PMID: 34289068)","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"5073_CR39","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1038\/s41467-019-10307-9","volume":"10","author":"P Bandopadhayay","year":"2019","unstructured":"Bandopadhayay P, Piccioni F, O\u2019Rourke R et al (2019) Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma. Nat Commun 10(1):2400. https:\/\/doi.org\/10.1038\/s41467-019-10307-9. (PMID: 31160565)","journal-title":"Nat Commun"},{"key":"5073_CR40","doi-asserted-by":"publisher","first-page":"1160227","DOI":"10.3389\/fcell.2023.1160227","volume":"11","author":"T Sharma","year":"2023","unstructured":"Sharma T, Olea-Flores M, Imbalzano AN (2023) Regulation of the Wnt signaling pathway during myogenesis by the mammalian SWI\/SNF ATPase BRG1. Front Cell Dev Biol 11:1160227. https:\/\/doi.org\/10.3389\/fcell.2023.1160227. (PMID: 37484913)","journal-title":"Front Cell Dev Biol"},{"key":"5073_CR41","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20202512","author":"JJ Milner","year":"2021","unstructured":"Milner JJ, Toma C, Quon S et al (2021) Bromodomain protein BRD4 directs and sustains CD8 T cell differentiation during infection. J Exp Med. https:\/\/doi.org\/10.1084\/jem.20202512. (PMID: 34037670)","journal-title":"J Exp Med"},{"issue":"23","key":"5073_CR42","doi-asserted-by":"publisher","first-page":"14680","DOI":"10.1021\/acs.jmedchem.0c01242","volume":"63","author":"M Wanior","year":"2020","unstructured":"Wanior M, Preuss F, Ni X et al (2020) Pan-SMARCA\/PB1 bromodomain inhibitors and their role in regulating adipogenesis. J Med Chem 63(23):14680\u201314699. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c01242. (PMID: 33216538)","journal-title":"J Med Chem"},{"key":"5073_CR43","first-page":"55","volume":"69","author":"DL Scott","year":"2004","unstructured":"Scott DL (2004) Radiological progression in established rheumatoid arthritis. J Rheumatol Suppl 69:55\u201365 (PMID: 15053455)","journal-title":"J Rheumatol Suppl"},{"issue":"3","key":"5073_CR44","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/00002281-199605000-00009","volume":"8","author":"FA Wollheim","year":"1996","unstructured":"Wollheim FA (1996) Established and new biochemical tools for diagnosis and monitoring of rheumatoid arthritis. Curr Opin Rheumatol 8(3):221\u2013225. https:\/\/doi.org\/10.1097\/00002281-199605000-00009. (PMID: 8796981)","journal-title":"Curr Opin Rheumatol"},{"issue":"7","key":"5073_CR45","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1038\/emm.2017.100","volume":"49","author":"J Lee","year":"2017","unstructured":"Lee J, Park C, Kim HJ et al (2017) Stimulation of osteoclast migration and bone resorption by C-C chemokine ligands 19 and 21. Exp Mol Med 49(7):e358. https:\/\/doi.org\/10.1038\/emm.2017.100. (PMID: 28729639)","journal-title":"Exp Mol Med"},{"issue":"5","key":"5073_CR46","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/S0002-9440(10)63016-7","volume":"159","author":"AR Pettit","year":"2001","unstructured":"Pettit AR, Ji H, von Stechow D et al (2001) TRANCE\/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol 159(5):1689\u20131699. https:\/\/doi.org\/10.1016\/S0002-9440(10)63016-7. (PMID: 11696430)","journal-title":"Am J Pathol"},{"issue":"1","key":"5073_CR47","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/rheumatology\/kev312","volume":"55","author":"Y Xiao","year":"2016","unstructured":"Xiao Y, Liang L, Huang M et al (2016) Bromodomain and extra-terminal domain bromodomain inhibition prevents synovial inflammation via blocking IkappaB kinase-dependent NF-kappaB activation in rheumatoid fibroblast-like synoviocytes. Rheumatology 55(1):173\u2013184. https:\/\/doi.org\/10.1093\/rheumatology\/kev312. (PMID: 26324948)","journal-title":"Rheumatology"},{"issue":"2","key":"5073_CR48","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1136\/annrheumdis-2014-205809","volume":"75","author":"K Klein","year":"2016","unstructured":"Klein K, Kabala PA, Grabiec AM et al (2016) The bromodomain protein inhibitor I-BET151 suppresses expression of inflammatory genes and matrix degrading enzymes in rheumatoid arthritis synovial fibroblasts. Ann Rheum Dis 75(2):422\u2013429. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205809. (PMID: 25467295)","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"5073_CR49","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1002\/art.22175","volume":"54","author":"F De Benedetti","year":"2006","unstructured":"De Benedetti F, Rucci N, Del FA et al (2006) Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system. Arthritis Rheum 54(11):3551\u20133563. https:\/\/doi.org\/10.1002\/art.22175. (PMID: 17075861)","journal-title":"Arthritis Rheum"},{"issue":"12","key":"5073_CR50","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1172\/JCI26132","volume":"115","author":"H Kitaura","year":"2005","unstructured":"Kitaura H, Zhou P, Kim HJ, Novack DV, Ross FP, Teitelbaum SL (2005) M-CSF mediates TNF-induced inflammatory osteolysis. J Clin Invest 115(12):3418\u20133427. https:\/\/doi.org\/10.1172\/JCI26132. (PMID: 16294221)","journal-title":"J Clin Invest"},{"issue":"12","key":"5073_CR51","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1172\/JCI11176","volume":"106","author":"J Lam","year":"2000","unstructured":"Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL (2000) TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 106(12):1481\u20131488. https:\/\/doi.org\/10.1172\/JCI11176. (PMID: 11120755)","journal-title":"J Clin Invest"},{"key":"5073_CR52","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0083-6729(06)74015-8","volume":"74","author":"I Nakamura","year":"2006","unstructured":"Nakamura I, Jimi E (2006) Regulation of osteoclast differentiation and function by interleukin-1. Vitam Horm 74:357\u2013370. https:\/\/doi.org\/10.1016\/S0083-6729(06)74015-8. (PMID: 17027523)","journal-title":"Vitam Horm"},{"issue":"1","key":"5073_CR53","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1136\/ard.2008.104786","volume":"69","author":"K Polzer","year":"2010","unstructured":"Polzer K, Joosten L, Gasser J et al (2010) Interleukin-1 is essential for systemic inflammatory bone loss. Ann Rheum Dis 69(1):284\u2013290. https:\/\/doi.org\/10.1136\/ard.2008.104786. (PMID: 19196726)","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"5073_CR54","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","volume":"473","author":"BF Boyce","year":"2008","unstructured":"Boyce BF, Xing L (2008) Functions of RANKL\/RANK\/OPG in bone modeling and remodeling. Arch Biochem Biophys 473(2):139\u2013146. https:\/\/doi.org\/10.1016\/j.abb.2008.03.018. (PMID: 18395508)","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"5073_CR55","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00774-020-01162-6","volume":"39","author":"N Udagawa","year":"2021","unstructured":"Udagawa N, Koide M, Nakamura M et al (2021) Osteoclast differentiation by RANKL and OPG signaling pathways. J Bone Miner Metab 39(1):19\u201326. https:\/\/doi.org\/10.1007\/s00774-020-01162-6. (PMID: 33079279)","journal-title":"J Bone Miner Metab"},{"issue":"4","key":"5073_CR56","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/sj.emboj.7600564","volume":"24","author":"J Gohda","year":"2005","unstructured":"Gohda J, Akiyama T, Koga T, Takayanagi H, Tanaka S, Inoue J (2005) RANK-mediated amplification of TRAF6 signaling leads to NFATc1 induction during osteoclastogenesis. Embo J 24(4):790\u2013799. https:\/\/doi.org\/10.1038\/sj.emboj.7600564. (PMID: 15678102)","journal-title":"Embo J"},{"issue":"10","key":"5073_CR57","doi-asserted-by":"publisher","first-page":"706","DOI":"10.14348\/molcells.2017.0225","volume":"40","author":"JH Park","year":"2017","unstructured":"Park JH, Lee NK, Lee SY (2017) Current understanding of RANK signaling in osteoclast differentiation and maturation. Mol Cells 40(10):706\u2013713. https:\/\/doi.org\/10.14348\/molcells.2017.0225. (PMID: 29047262)","journal-title":"Mol Cells"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-024-05073-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-024-05073-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-024-05073-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T13:17:03Z","timestamp":1740057423000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-024-05073-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,7]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["5073"],"URL":"https:\/\/doi.org\/10.1007\/s11010-024-05073-2","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,7]]},"assertion":[{"value":"27 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"All patients recruited in this study provided informed consent for participation. The animal experimental procedures complied with the National Research Council\u2019s Guide for the Care and Use of Laboratory Animals. The research protocols were approved by the Ethical Committee of the Affiliated Hospital of Qingdao University (Ethical committee number: QYFYWZLL26707) and the Ethical Committee of Animal Experiments of Qingdao University (Ethical committee number: AHQU-MAL20210428).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors gave their consent for publication and have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}